PharmacogeneticsIndividualized MedicineCytochrome P-450 CYP2D6Biomarkers, PharmacologicalPolymorphism, GeneticDrug-Related Side Effects and Adverse ReactionsPharmaceutical PreparationsDrug TherapyKnowledge BasesGenotypeMetabolic Detoxication, DrugAryl Hydrocarbon HydroxylasesWarfarinVitamin K Epoxide ReductasesGenetic VariationPolymorphism, Single NucleotideDrug DesignPharmacokineticsEducation, Pharmacy, ContinuingGenetic Testing6-MercaptopurineGenome, HumanMethyltransferasesCytochrome P-450 Enzyme SystemGenome-Wide Association StudyPharmacology, ClinicalBiotransformationPhenotypeGenomicsPharmacy ResidenciesGenetic ServicesClinical Trials as TopicAnticoagulantsTranslational Medical ResearchDihydrouracil Dehydrogenase (NADP)Immunogenetic ProcessesAntineoplastic AgentsCardiovascular AgentsNeoplasmsDrug RepositioningMedical OncologyInterdisciplinary StudiesCytochrome P-450 CYP3AXenobioticsMixed Function OxygenasesBiological PsychiatryUnited States Food and Drug AdministrationHuman Genome ProjectGlycine DehydrogenaseHapMap ProjectBiological OntologiesDrug Dosage CalculationsGenetic Predisposition to DiseaseHaplotypesSleep Arousal DisordersData MiningTechnology, PharmaceuticalAzathioprine